Medical Xpress: Lower ‘bad’ cholesterol and higher fat-transport markers linked to less Alzheimer’s risk

June 2, 2025

Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article.   Read More

Knowridge: Blood fat levels may predict Alzheimer’s risk, new study finds

June 2, 2025

Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article.   Read More

The Munich Eye: Lowering Bad Cholesterol Linked to Reduced Alzheimer’s Risk

June 2, 2025

Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was mentioned in this article.   Read More

Technology Networks: Lower “Bad” Cholesterol Levels Associated With Reduced Alzheimer’s Risk

June 2, 2025

Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article.   Read More

yahoo! finance: UT Health San Antonio researchers discover new links between heart disease and dementia

June 2, 2025

Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article.   Read More

WOAI TV (NEWS4SA): UT Health San Antonio study links heart disease markers to higher Alzheimer’s risk

June 2, 2025

Sokratis Charisis, MD, a researcher with the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was quoted in this article in which Sudha Seshadri, MD, founding director of the Glenn Biggs Institute for Alzheimer’s and Neurodegenerative Diseases, was also mentioned.   Read More